key: cord-0845833-frbg673x
authors: Tung-Chen, Yale; Marín-Baselga, Raquel; Soriano-Arroyo, Rubén; Muñoz-del Val, Elena
title:  Time course of lung changes on thoracic ultrasound of mildCOVID-19 patients
date: 2020-11-19
journal: nan
DOI: 10.1016/j.eimce.2020.05.004
sha: f3521c8086a0261423b5ee527700450385a00760
doc_id: 845833
cord_uid: frbg673x

nan

On 11 March 2020, the World Health Organisation declared a pandemic caused by severe acute respiratory syndrome (SARS) due to coronavirus 2 (SARS-CoV-2) infection. The virus has spread to over 180 countries, with 2,815,347 confirmed cases and 197,516 deaths. 1 It is known that the spectrum of disease severity is broad, with many patients (80%) who are asymptomatic or mildly symptomatic (fever, cough and asthenia), and that the disease's mortality rate may be less than 1%. 2 Treatment is symptomatic, as these cases have a selflimiting course of 1-2 weeks, and isolation at home is recommended. 3 

There is growing evidence on radiological findings in the disease caused by coronavirus . A chest X-ray offers little sensitivity for detecting abnormalities (absent in over 40% of patients). 2 Computed tomography (CT) of the chest is more sensitive, but has multiple disadvantages: the associated exposure to ionising radiation in mild disease; issues of availability and resource rationing; the patient's haemodynamic instability for transfer; and the risk of transmission of the infection, among other disadvantages, may eclipse the technique's potential benefits.

There is currently no evidence on the usefulness of thoracic ultrasound when monitoring the disease. The aim of this case series is to report the sequential thoracic ultrasound findings in 3 patients with mild COVID-19, from onset of symptoms up to complete resolution on ultrasound.

We report the cases of a 35-year-old man (patient 1), a 35-year-old woman (patient 2) and a 45-year-old woman (patient 3) who visited the emergency department with a dry cough, asthenia and low-grade fever. Physical examination was normal, and all 3 had positive reverse transcriptase-polymerase chain reaction (RT-PCR) tests of nasopharyngeal exudate. 

There is growing evidence for the use of imaging techniques in the management of COVID-19. A previous study of 1,049 patients who had RT-PCR and CT scans found CT to be more sensitive to abnormalities (59 versus 88%, respectively). 4 This would suggest that CT should be considered as a detection tool, particularly in epidemic areas. Another study in 21 patients with pneumonia caused by uncomplicated COVID-19 5 found that performing CT scans every 4 days enabled physicians to determine that radiological findings peaked on approximately day 10, and resolution was very gradual, persisting beyond day 26, when a follow-up CT scan was performed.

Subpleural consolidations, pleural irregularity and B-lines in the context of this pandemic may suggest lung infection caused by COVID-19. As exemplified in the 3 cases reported, it is possible to correlate thoracic ultrasound findings to symptoms and their resolution, which in 2 of the cases this did not happen until the fifth week, when A-lines (normal aeration pattern) were seen to reappear. This accounts for some of the residual symptoms that many patients report after discharge and avoids other, more invasive complementary tests.

To date, thoracic ultrasound and CT have been used for the diagnosis and follow-up of patients with COVID-19, particularly in patients with residual symptoms; however, these resources may not be available everywhere or their use may be contraindicated. Hence, alternative methods must be considered.

Thoracic ultrasound is harmless and may be completed quickly by following simple, easily applied protocols. Currently there is a wide range of available portable, pocket-sized ultrasound devices which allow studies to be performed on asymptomatic and unstable patients, either in their homes or in a hospital setting. Although there is ongoing debate about how it should be applied, there is a general consensus on its usefulness. 6 The main limitation of thoracic ultrasound is its low specificity, meaning its findings can be similar to findings in different diseases. However, in the current pandemic, detection of these findings may be highly suggestive of COVID-19 infection.

In conclusion, it is worthwhile to consider using thoracic ultrasound in follow-up until complete resolution of symptoms.

Declaramos que no existe financiación externa ni conflicto de intereses por parte de los autores. 

Clinical Characteristics of Coronavirus Disease 2019 in China

Guidance for Corona Virus Disease 2019: Prevention, Control, Diagnosis and Management National Health Commission (NHC) of the PRC

National Administration of Traditional Chinese Medicine of the PRC, General Office

Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases

Time Course of Lung Changes On Chest CT During Recovery From 2019 Novel Coronavirus (COVID-19) Pneumonia. Radiology

POINT: Should the Use of Diagnostic Pointof-Care Ultrasound in Patient Care Require Hospital Privileging/Credentialing? Yes